Veterinary Medicines

Canaural ear drops, suspension for dogs and cats

Authorised
  • Diethanolamine fusidate
  • Framycetin sulfate
  • Prednisolone
  • Nystatin
Download as PDF

Product identification

Medicine name:
Canaural ear drops, suspension for dogs and cats
Active substance:
  • Diethanolamine fusidate
  • Framycetin sulfate
  • Prednisolone
  • Nystatin
Target species:
  • Dog
  • Cat
Route of administration:
  • Auricular use

Product details

Active substance and strength:
  • Diethanolamine fusidate
    5.00
    milligram(s)
    /
    1.00
    gram(s)
  • Framycetin sulfate
    5.00
    milligram(s)
    /
    1.00
    gram(s)
  • Prednisolone
    2.50
    milligram(s)
    /
    1.00
    gram(s)
  • Nystatin
    100000.00
    international unit(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Ear drops, suspension
Withdrawal period by route of administration:
  • Auricular use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS02CA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • High density polyethylene squeeze dropper bottle, supplied in pack sizes of 1x100ml.
  • High density polyethylene squeeze dropper bottle, supplied in pack sizes of 1x25ml
  • High density polyethylene squeeze dropper bottles, supplied in pack sizes of 10x15ml
  • High density polyethylene squeeze dropper bottle, supplied in pack sizes of 1x15ml

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Dechra Veterinary Products A/S
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera d.d.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10803/003/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."